Axsome Therapeutics Inc (AXSM) Company Profile & Statistics

Axsome Therapeutics Inc
AXSM
(Nasdaq - US)
Closed
70.27
-1.23 (-1.72%)
in:usd•As of: Jan 27, 2023 15:59 UTC -5
Open
72.27
High
72.87
Low
69.29

About Axsome Therapeutics Inc

CEO

Herriot Tabuteau

Headquarters

22 cortlandt street, 16th floor

new york, ny 10007, united states

Auditor

Ernst & Young LLP

Employees

108

Share Holders

Website

http://axsome.com

Industry

biotechnology

Sector

health technology

Company Overview

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

Axsome Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	3.05B
Enterprise Value	2.92B
Enterprise Value/EBITDA (ttm)	-19.82
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	17.68
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	44.36%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-183.98%
Return on Equity (ttm)	-312.00%
Return on Invested Capital (ttm)	-170.39%
Return on Assets (ttm)	-90.97%

Income Statement

Revenue (ttm)	25.67M
Revenue Per Share (ttm)	0.59
Gross Profit (ttm)	22.76M
EBITDA (ttm)³	-147.27M
Net Income Avi to Common (ttm)	-159.87M
Diluted EPS (ttm)	-4.06

Share Statistics

Beta (5Y Monthly)	1.83
52-Week Change	166.98%
S&P500 52-Week Change	-8.15%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	43.43M
Dividend Yield	0.00%
Float ⁴	32.13M
% Held by Insiders	26.00%
% Held by Institutions	59.71%

Balance Sheet

Total Cash (mrq)	227.52M
Total Cash Per Share (mrq)	5.24
Total Debt (mrq)	93.91M
Total Debt/Equity (mrq)	59.68%
Current Ratio (mrq)	4.19%
Quick Ratio (mrq)	4.15%
Book Value Per Share (mrq)	3.62

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.13
Free Cash Flow (ytd)	-89.47M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Axsome Therapeutics Inc

Trade With A Regulated Broker